OOMA:NYSEOoma, Inc. Analysis
Data as of 2026-06-14 - not real-time
$17.55
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Ooma’s price is trading above its short‑term moving average while staying above the 50‑day trend line, signaling a bullish alignment despite a recent bearish MACD crossover that hints at short‑term momentum weakness. Volume remains stable and the RSI hovers around the midpoint, suggesting neither overbought nor oversold conditions. The stock sits comfortably above a key support zone, providing a cushion against further downside. Recent product recognition for Ooma AirDial reinforces its competitive positioning in the POTS replacement market, and the company’s roadmap emphasizes AI‑driven expansion. Forward earnings estimates have improved dramatically, and the discounted cash‑flow model points to a valuation substantially higher than the current market price, implying a material upside potential.
However, the equity exhibits elevated short‑term volatility and a modest beta, reflecting sensitivity to market swings. The balance sheet shows a moderate debt load relative to equity, and cash flow generation remains healthy, supporting ongoing investment. Investor interest is evident from multiple upcoming conference appearances, which could catalyze further price appreciation. Overall, the blend of technical bullishness, strong growth fundamentals, and a compelling valuation gap makes Ooma an attractive candidate for investors with a medium‑to‑long horizon.
However, the equity exhibits elevated short‑term volatility and a modest beta, reflecting sensitivity to market swings. The balance sheet shows a moderate debt load relative to equity, and cash flow generation remains healthy, supporting ongoing investment. Investor interest is evident from multiple upcoming conference appearances, which could catalyze further price appreciation. Overall, the blend of technical bullishness, strong growth fundamentals, and a compelling valuation gap makes Ooma an attractive candidate for investors with a medium‑to‑long horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish placement above short‑term moving averages
- Bearish MACD histogram indicating potential near‑term pullback
- Stable volume and support level providing downside protection
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and accelerating forward EPS
- DCF‑derived fair value far above current price suggesting upside
- Product award and AI expansion fueling market share gains
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustained cash flow generation supporting reinvestment
- Undervalued relative to peers with a high growth trajectory
- Long‑term tailwinds in UCaaS and AI‑enabled communications
Key Metrics & Analysis
Financial Health
Revenue Growth24.80%
Profit Margin3.17%
P/E Ratio53.2
ROE10.00%
ROA3.04%
Debt/Equity70.82
P/B Ratio5.0
Op. Cash Flow$30.4M
Free Cash Flow$35.6M
Industry P/E36.8
Technical Analysis
TrendBullish
RSI49.8
Support$16.25
Resistance$21.96
MA 20$18.02
MA 50$17.02
MA 200$13.34
MACDBearish
VolumeStable
Fear & Greed Index89.86
Valuation
Fair Value$44.74
Target Price$23.00
Upside/Downside31.05%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.88
Volatility51.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.